Last reviewed · How we verify

NCT05620745

Comparison of Resilience Between ADHD and Controls.

Status unknown Last updated 17 November 2022
What this trial tests

trial in ADHD; Resilience; Stress in 400 participants. Status unknown.

Timeline
1 October 2022
Primary endpoint
1 October 2023
1 November 2023

Quick facts

Lead sponsorChang Gung Memorial Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment400
Start date1 October 2022
Primary completion1 October 2023
Estimated completion1 November 2023
Sites1 location across Taiwan

Conditions studied

Sponsor

Chang Gung Memorial Hospital

Who can join

Adults 6 to 18, any sex, with ADHD; Resilience; Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To explore if resilience serves as a mediator between adverse life events and emotional and behavioral problems, and compare the difference of resilience and its mediating effects between children and adolescents with and without ADHD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05620745.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing